.

ISSN 2063-5346
For urgent queries please contact : +918130348310

Development and Validation of RP-HPLC Methods for Simultaneous Determination of Moxifloxacin HCl and Ketorolac Tromethamine in Bulk and Marketed Formulation

Main Article Content

Ujwala Wasnik, Kedar Jagtap, Bhimashankar Devkar, Sameer Lakade, Ankita Patil, Padmaja Kore, Minal Harde
» doi: 10.31838/ecb/2023.12.sa1.216

Abstract

A rapid, accurate, selective, and sensitive RP-HPLC method has been developed and validated for estimation of moxifloxacin hydrochloride (MXF) and ketorolac tromethamine (KTA) in the bulk and ophthalmic formulation. Method: The chromatographic separation was achieved on ODS Phenomenex C18 column (250mm × 4.6mm, 5 μm). The compound was separated using mobile phase 0.025M Potassium dihydrogen phosphate solution: acetonitrile: methanol (30:35:35v/v/v). The pH of mobile phase was adjusted to 3.0 with ortho-phosphoric acid, flow rate was 1.0 ml/min and 25°C column temperature and detection wavelength was set at 300 nm for overall analysis. Results: The retention time of MXF and KTA was obtained at 2.67 and 5.39 min, respectively. The linearity study was performed in the concentration range of 2 to 20 μg/ml for MXF and KTA with correlation coefficient was found to be 0.999 for both drugs. The percentage purity of MXF and KTA was obtained in the range 98-102%. The limit of detection was 0.148 μg/ml and 0.272μg/ml and limit of quantification was 0.449 μg/ml and 0.824 μg/ml, respectively for MXF and KTA.

Article Details